191 related articles for article (PubMed ID: 23467233)
1. Turning off the inflammatory, but not the metabolic, flames.
Calay ES; Hotamisligil GS
Nat Med; 2013 Mar; 19(3):265-7. PubMed ID: 23467233
[No Abstract] [Full Text] [Related]
2. An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice.
Reilly SM; Chiang SH; Decker SJ; Chang L; Uhm M; Larsen MJ; Rubin JR; Mowers J; White NM; Hochberg I; Downes M; Yu RT; Liddle C; Evans RM; Oh D; Li P; Olefsky JM; Saltiel AR
Nat Med; 2013 Mar; 19(3):313-21. PubMed ID: 23396211
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.
Oral EA; Reilly SM; Gomez AV; Meral R; Butz L; Ajluni N; Chenevert TL; Korytnaya E; Neidert AH; Hench R; Rus D; Horowitz JF; Poirier B; Zhao P; Lehmann K; Jain M; Yu R; Liddle C; Ahmadian M; Downes M; Evans RM; Saltiel AR
Cell Metab; 2017 Jul; 26(1):157-170.e7. PubMed ID: 28683283
[TBL] [Abstract][Full Text] [Related]
4. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro.
Zhou Z; Qi J; Lim CW; Kim JW; Kim B
Toxicology; 2020 Nov; 444():152579. PubMed ID: 32905826
[TBL] [Abstract][Full Text] [Related]
5. Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction.
Cruz VH; Arner EN; Wynne KW; Scherer PE; Brekken RA
Mol Metab; 2018 Oct; 16():139-149. PubMed ID: 29935921
[TBL] [Abstract][Full Text] [Related]
6. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell.
He Q; Xia X; Yao K; Zeng J; Wang W; Wu Q; Tang R; Zou X
Life Sci; 2019 Dec; 239():117010. PubMed ID: 31672578
[TBL] [Abstract][Full Text] [Related]
7. Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKK
Beyett TS; Gan X; Reilly SM; Chang L; Gomez AV; Saltiel AR; Showalter HD; Tesmer JJG
Mol Pharmacol; 2018 Oct; 94(4):1210-1219. PubMed ID: 30082428
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer.
Bishop RT; Marino S; de Ridder D; Allen RJ; Lefley DV; Sims AH; Wang N; Ottewell PD; Idris AI
Cancer Lett; 2019 May; 450():76-87. PubMed ID: 30790681
[TBL] [Abstract][Full Text] [Related]
9. The multiple facets of the fat tissue.
Rocha VZ; Libby P
Thyroid; 2008 Feb; 18(2):175-83. PubMed ID: 18279018
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the protein kinase IKKepsilon attenuates neuropathic pain in mice.
Möser CV; Möller M; Fleck SC; Thomas D; Geisslinger G; Niederberger E
Neuropharmacology; 2019 Mar; 146():198-211. PubMed ID: 30528326
[TBL] [Abstract][Full Text] [Related]
11. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.
Yuan M; Konstantopoulos N; Lee J; Hansen L; Li ZW; Karin M; Shoelson SE
Science; 2001 Aug; 293(5535):1673-7. PubMed ID: 11533494
[TBL] [Abstract][Full Text] [Related]
12. Food Ingredients as Anti-Obesity Agents.
Saito M; Yoneshiro T; Matsushita M
Trends Endocrinol Metab; 2015 Nov; 26(11):585-587. PubMed ID: 26421678
[TBL] [Abstract][Full Text] [Related]
13. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
Sasaoka T; Wada T; Tsuneki H
Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857
[TBL] [Abstract][Full Text] [Related]
14. Amlexanox ameliorates acetaminophen-induced acute liver injury by reducing oxidative stress in mice.
Qi J; Zhou Z; Lim CW; Kim JW; Kim B
Toxicol Appl Pharmacol; 2019 Dec; 385():114767. PubMed ID: 31697998
[TBL] [Abstract][Full Text] [Related]
15. No need to sweat: is dieting enough to alleviate insulin resistance in obesity?
Watt MJ; Bruce CR
J Physiol; 2009 Nov; 587(Pt 21):5001-2. PubMed ID: 19880871
[No Abstract] [Full Text] [Related]
16. Taurine-mediated browning of white adipose tissue is involved in its anti-obesity effect in mice.
Guo YY; Li BY; Peng WQ; Guo L; Tang QQ
J Biol Chem; 2019 Oct; 294(41):15014-15024. PubMed ID: 31427436
[TBL] [Abstract][Full Text] [Related]
17. A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance.
Kamon J; Yamauchi T; Muto S; Takekawa S; Ito Y; Hada Y; Ogawa W; Itai A; Kasuga M; Tobe K; Kadowaki T
Biochem Biophys Res Commun; 2004 Oct; 323(1):242-8. PubMed ID: 15351728
[TBL] [Abstract][Full Text] [Related]
18. Celastrol alleviates metabolic disturbance in high-fat diet-induced obese mice through increasing energy expenditure by ameliorating metabolic inflammation.
Yang X; Wu F; Li L; Lynch EC; Xie L; Zhao Y; Fang K; Li J; Luo J; Xu L; Zou X; Lu F; Chen G
Phytother Res; 2021 Jan; 35(1):297-310. PubMed ID: 32776627
[TBL] [Abstract][Full Text] [Related]
19. Cellular energy sensor balances the scales.
Small CJ; Carling D; Bloom SR
Nat Med; 2004 Jul; 10(7):681-2. PubMed ID: 15229514
[No Abstract] [Full Text] [Related]
20. Drug treatment of obesity: established and emerging therapies.
Isidro ML; Cordido F
Mini Rev Med Chem; 2009 Jun; 9(6):664-73. PubMed ID: 19519492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
